Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures

PLoS Pathog. 2021 Jan 13;17(1):e1009215. doi: 10.1371/journal.ppat.1009215. eCollection 2021 Jan.

Abstract

Poxvirus systems have been extensively used as vaccine vectors. Herein a RNA-Seq analysis of intramuscular injection sites provided detailed insights into host innate immune responses, as well as expression of vector and recombinant immunogen genes, after vaccination with a new multiplication defective, vaccinia-based vector, Sementis Copenhagen Vector. Chikungunya and Zika virus immunogen mRNA and protein expression was associated with necrosing skeletal muscle cells surrounded by mixed cellular infiltrates. The multiple adjuvant signatures at 12 hours post-vaccination were dominated by TLR3, 4 and 9, STING, MAVS, PKR and the inflammasome. Th1 cytokine signatures were dominated by IFNγ, TNF and IL1β, and chemokine signatures by CCL5 and CXCL12. Multiple signatures associated with dendritic cell stimulation were evident. By day seven, vaccine transcripts were absent, and cell death, neutrophil, macrophage and inflammation annotations had abated. No compelling arthritis signatures were identified. Such injection site vaccinology approaches should inform refinements in poxvirus-based vector design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Genetic Vectors / administration & dosage*
  • Genetic Vectors / genetics
  • Genome, Viral
  • Immunity, Innate / immunology*
  • Injection Site Reaction / immunology*
  • Mice
  • Mice, Inbred C57BL
  • RNA-Seq
  • Vaccination / methods*
  • Vaccines, Synthetic / administration & dosage*
  • Vaccines, Synthetic / immunology
  • Vaccinia / genetics
  • Vaccinia / immunology*
  • Vaccinia / metabolism
  • Vaccinia / virology
  • Vaccinia virus / isolation & purification
  • Vaccinology
  • Zika Virus / isolation & purification
  • Zika Virus Infection / genetics
  • Zika Virus Infection / immunology*
  • Zika Virus Infection / metabolism
  • Zika Virus Infection / virology

Substances

  • Vaccines, Synthetic

Grants and funding

JEH was supported by an Australian Government Research Training Program scholarship (https://ppl.app.uq.edu.au/content/uq-and-rtp-research-scholarships-procedures) via the Faculty of Medicine at the University of Queensland (UQ). JEH also received funding from the Global Change Institute/Graduate School at UQ (https://graduate-school.uq.edu.au/current-students/global-change-scholars-program). NAP was awarded an Advance Queensland Research Fellowship by the Queensland Government, Australia (https://advance.qld.gov.au/assets/includes/docs/research-fellowships-guidelines.pdf), with co-funding from Sementis (https://www.sementis.com.au/). AS hold an Investigator grant (APP1173880) from the National Health and Medical Research Council (NHMRC) of Australia (https://www.nhmrc.gov.au/). The project was also funded in part by an NHMRC Project grant APP1141421. We also thank Dr J Aylward (Oncolin) and Prof Ed Westaway (Royal Australian Air Force Association) for their kind philanthropic donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.